The New Guest at Thanksgiving This Year Is Ozempic

People taking weight-loss and diabetes drugs feel a sense of freedom as well as fear of judgment from family as they prepare for holiday gatherings

PHOTO ILLUSTRATION BY ELENA SCOTTI/THE WALL STREET JOURNAL, ISTOCK, REUTERS

This Thanksgiving collides with a national conversation about Ozempic, Wegovy and other blockbuster weight-loss and diabetes drugs. People taking the medications say they don’t want to be the hot topic at the table.

Zohray Brennan, who has been on Ozempic for roughly a year, looks forward to eating smaller portions of everything, including cranberry sauce and coconut custard pie. But when it comes to wine, which had been one of her favorite parts of the annual gathering, she is trepidatious. 

Copyright ©2023 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8

Continue reading your article with
a WSJ subscription

Subscribe Now

Already a subscriber? Sign In